Evidence map›Paper›PMID 38504000›Full record

ArticleJapanese journal of radiology2024

Organ-specific accuracy of [

Birte Molvik Gideonse, Magnus Birkeland, Mie Holm Vilstrup, Peter Grupe, Mohammad Naghavi-Behzad, Christina H Ruhlmann, Oke Gerke, Malene Grubbe Hildebrandt

Open access · hybridAbstract read
In one paragraph

Article in Japanese journal of radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. The Prognostic Value of Biomarkers Identified by [Diagnostics (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Immune-related [Cancer imaging : the official publication of the International Cancer Imaging Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Birte Molvik Gideonse *Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Magnus Birkeland *Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Mie Holm VilstrupDepartment of Clinical Research, University of Southern Denmark, Odense, Denmark.
Peter GrupeDepartment of Clinical Research, University of Southern Denmark, Odense, Denmark.
Mohammad Naghavi-BehzadDepartment of Clinical Research, University of Southern Denmark, Odense, Denmark. MNB91@rsyd.dk.ORCID http://orcid.org/0000-0002-6761-8126
Christina H RuhlmannDepartment of Clinical Research, University of Southern Denmark, Odense, Denmark.
Oke GerkeDepartment of Clinical Research, University of Southern Denmark, Odense, Denmark.
Malene Grubbe HildebrandtDepartment of Clinical Research, University of Southern Denmark, Odense, Denmark.
University of Southern Denmark · DK

Funding

Odense Universitetshospital Centre for Personalized Response Monitoring in Oncology (PREMIO)
6 · The paper itself

Abstract

purposeThis study aimed to determine the organ-specific accuracy of [ MATERIALS AND

methodsThis registry-based study included individuals who had undergone surgical removal of melanoma and were undergoing adjuvant ICI treatment (either nivolumab or pembrolizumab). The study specifically enrolled patients who had undergone both a baseline and at least one subsequent follow-up [

resultsA total of 123 patients with 363 [

conclusion[

Indexed as

Fluorodeoxyglucose F18Immune Checkpoint InhibitorsMelanomaPositron Emission Tomography Computed TomographyRadiopharmaceuticalsAdultAgedAged, 80 and overAntibodies, Monoclonal, HumanizedChemotherapy, AdjuvantFemaleHumansMaleMiddle AgedNivolumabRegistriesAntibodies, Monoclonal, HumanizedFluorodeoxyglucose F18Immune Checkpoint InhibitorsNivolumabpembrolizumabRadiopharmaceuticals[18F]FDG-PET/CTImmune checkpoint inhibitorImmune-related adverse eventsirAEsMelanoma

Identifiers

PMID38504000
PMCPMC11217074
OpenAlexW4393010485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.